Gregory Orloff

Assistant Professor

19922010
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Gregory Orloff is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles
Stem Cell Transplantation Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Nitric Oxide Synthase Type II Medicine & Life Sciences
Cell- and Tissue-Based Therapy Medicine & Life Sciences
Tumor Virus Infections Medicine & Life Sciences
Leukocyte Transfusion Medicine & Life Sciences
Chimerism Medicine & Life Sciences
Cells Chemical Compounds

Research Output 1992 2010

Pegfilgrastim appears equivalent to daily dosing of filgrastim to treat neutropenia after autologous peripheral blood stem cell transplantation in patients with non-hodgkin lymphoma

Rifkin, R., Spitzer, G., Orloff, G., Mandanas, R., McGaughey, D., Zhan, F., Boehm, K. A., Asmar, L. & Beveridge, R., Jan 1 2010, In : Clinical Lymphoma, Myeloma and Leukemia. 10, 3, p. 186-191 6 p.

Research output: Contribution to journalArticle

Peripheral Blood Stem Cell Transplantation
Neutropenia
Non-Hodgkin's Lymphoma
Carmustine
Erythrocyte Transfusion

Ovarian cancer care: A case study in determined living

Umlauf, R. L. & Orloff, G., Jan 1 2006, In : Onkologie. 29, 1-2, p. 27-29 3 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Hospice Care
Quality of Life
Palliative Care
Therapeutics

Intensive graft-versus-host disease prophylaxis is required after unrelated-donor nonmyeloablative stem cell transplantation

Loren, A. W., Luger, S. M., Stadtmauer, E. A., Tsai, D. E., Schuster, S., Nasta, S. D., Goldstein, S. C., Perl, A., Orloff, G., Oliver, J. C., Green, J., Emerson, S. G. & Porter, D. L., May 1 2005, In : Bone Marrow Transplantation. 35, 9, p. 921-926 6 p.

Research output: Contribution to journalArticle

Unrelated Donors
Stem Cell Transplantation
Graft vs Host Disease
Cyclosporine
Methotrexate

Allogeneic cell therapy for patients who relapse after autologous stem cell transplantation

Porter, D. L., Luger, S. M., Duffy, K. M., Stadtmauer, E. A., Laport, G., Schuster, S. J., Orloff, G., Tsai, D., McDaid, K., Kathakali, A., Leonard, D. G. B. & Antin, J. H., Jan 1 2001, In : Biology of Blood and Marrow Transplantation. 7, 4, p. 230-238 9 p.

Research output: Contribution to journalArticle

Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Recurrence
Chimerism
Graft vs Host Disease

Allogeneic cell therapy (act) after relapse from autologous stem cell transplantation (autosct)

Porter, D., Luger, S., Duffy, K., Orloff, G., Tsai, D., Stadtmauer, E., Laport, G., Schuster, S. & McDaid, K., Dec 1 2000, In : Blood. 96, 11 PART I

Research output: Contribution to journalArticle

Stem Cell Transplantation
Cell- and Tissue-Based Therapy
Stem cells
Chimerism
Tissue Donors